|Basic InformationMore InformationLatest News|HIV No Barrier to Getting Liver Transplant, Study FindsImmune Cell Discovery May One Day Lead to Herpes Vaccine: StudyHalf of People With Hepatitis C Don't Complete Needed Tests: CDCNew Guidelines Suggest HIV Screening for All AdultsHIV 'Cure' Looks 'Promising,' Danish Scientists ContendSofosbuvir Shows Promise for Chronic Hepatitis C InfectionStudy Hints of Links Between HPV and Lung CancerCould Self-Testing Help Overcome HIV/AIDS Epidemic?Experimental Drug May Work Against Hepatitis CHIV Prevalence Is High Among High-Risk HeterosexualsCDC: 1 in 50 Poor, Straight Urban Americans Infected With HIVHIV Infection Linked to Risk of Acute Myocardial InfarctionHIV May Raise Risk of Heart AttackResearchers Describe 1st 'Functional Cure' of HIV in BabyU.S. AIDS-Relief Plan a Success, Report FindsMillions of Americans Have an STD: ReportCertain Skin Cancers More Common in HIV-Positive PeopleDrug Users Are 'Super-Spreaders' of Hepatitis C, Study FindsStudy Pinpoints Optimal Treatment Window for HIVGeneric Three-Pill HIV Regimen Could Result in Big SavingsSome HPV-Linked Cancers Rising in U.S.: ReportNew Pills Show Promise for Hepatitis CFulyzaq Approved for Diarrhea in People With HIV/AIDSHepatitis: The Hidden HazardSmoking Deadlier For HIV Patients Than Virus Itself: StudyKids With HIV at Risk of Heart Disease, Study SaysUse of Clinical Decision-Support System Can Improve HIV CareAmong Black Americans, HIV Takes a Greater TollNew HIV Infections Highest Among Urban Gay, Bisexual Men: CDCHIV Infections Continue to Hit Young Americans HardAIDS Deaths, New HIV Infections Continue to Drop WorldwideU.S. Task Force Backs HIV Screening for All 15 to 65Antiviral Therapy for Hepatitis C May Thwart Liver CancerHigh-Dose Vitamins Don't Halt HIV Progression, DeathExperimental Vaccine Might Help Women Already Infected With HPVMore Stomach, Esophageal Cancers Seen in AIDS Patients Than OthersScientists Probe How Some HIV Patients Resist AIDSImproved HIV Care Boosts Life Expectancy at Clinic, Study FoundAntiretrovirals Increasingly Used for HIV in the U.S.More Americans Get Effective HIV Treatment, Study SaysOnce-Daily Pill Approved to Treat HIVHepatitis C Treatment May Hamper Kids' GrowthGonorrhea Resistant to All But One Antibiotic: CDCNew Clues to How HIV Infects Body's CellsOnly 1 in 4 Americans With HIV Has Virus Under Control: CDCHIV Drug-Resistance Up in Resource-Limited SettingsAll HIV Patients Should Take Meds Early On, Experts Now SayMom's HIV Drugs May Pass to Baby in Womb, Breast-FeedingNot All HIV Patients in U.S. Show Same Characteristics: StudyHIV Racial Disparities Noted for Men Who Have Sex With MenQuestions and AnswersLinksBook Reviews
Once-Daily Pill Approved to Treat HIV
by -- Scott Roberts
Updated: Aug 28th 2012
TUESDAY, Aug. 28 (HealthDay News) -- Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) has been approved by the U.S. Food and Drug Administration to treat adults with HIV, the virus that causes AIDS.
The combination drug, which only has to be taken once a day, interferes with enzymes that are needed for the virus to multiply, the FDA said in a news release.
The safety and effectiveness of Stribild were evaluated in clinical studies involving 1,408 adults. Of those treated with the new drug, between 88 percent and 90 percent had undetectable levels of HIV in their blood, compared with roughly 84 percent who had undetectable levels among those treated with other anti-HIV drugs, the agency said.
As with similar HIV medications, Stribild's label will include a boxed warning of the potential for a lethal buildup of lactic acid in the blood or severe liver problems, the FDA said.
The most common side effects reported during clinical testing included nausea and diarrhea. More serious but less common adverse reactions included new or worsening kidney problems, a drop in bone mineral density and immune system changes.
Foster City, Calif.-based drug maker Gilead Sciences will have to conduct additional studies of the drug's safety in women and children, how the drug may become resistant to the AIDS virus, and possible interactions with other drugs, the agency said.
The FDA has more about this approval.
This article: Copyright © 2012 HealthDay. All rights reserved.